CYNTHIA HUTSON: Open Payments
NPI 1598931396 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,999 in 125 payments from 22 companies in 2025. Trend: 2023 $1,293 · 2024 $1,767 · 2025 $1,999
Food & beverage: $1,999
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $264 |
| Novo Nordisk Inc | 13 | $232 |
| AstraZeneca Pharmaceuticals LP | 10 | $216 |
| Otsuka America Pharmaceutical, Inc. | 11 | $203 |
| Amgen Inc. | 14 | $165 |
| Corcept Therapeutics | 10 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $133 |
| Abbott Laboratories | 8 | $120 |
| Exact Sciences Corporation | 5 | $81 |
| Lilly USA, LLC | 2 | $49 |
Products named: REXULTI, Korlym, FARXIGA, Kerendia, OTEZLA, Wegovy, VRAYLAR, UBRELVY.
Industry payments across SC — which companies pay providers there.
